Page 258 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 258

Appendix Table C1.3. Trends in mortality rates (per 100,000 person-yr unless otherwise stated) or survival (continued)
                                        Author                Database       Groups             1980-84      1985-89        1990-94        1995-99      2000-04       2005-10     Statistical      Notes
                                        Year                                 (yr)                                                                                                 analysis
                                        PMID
                                        Tumor
                                        characteristics –
                                        grade
                                              24
                                        Merrill               SEER           Well diff.                      Referent       Referent       Referent                               OR (95% CI)      Data were
                                        2000                                 Moderately diff.                2.39 (2.04,  2.03 (1.72,      2.14                                   for death        reported
                                        10792091                             Poorly                          2.82)          2.39)          (1.80,                                 from prostate    only for
                                                                             diff./undiff.                   4.09 (3.48,  4.29 (3.63,      2.55)                                  cancer vs.       White and
                                                                             Unknown                         4.82)          5.06)          4.84                                   non-prostate     Black
                                                                                                             2.80 (2.35,  2.81 (2.34,      (4.06,                                 cancer,          patients.
                                                                                                             3.36)          3.38)          5.78)                                  stratified by
                                                                                                             (1988-89)      (1992-93)      3.55                                   grade.
                                                                                                                                           (2.92,
                                                                                                                                           4.31)
                                                                                                                                           (1994-
                                                                                                                                           95)
                                              40
                                        Merrill               SEER           Well-diff.                      16%            16%            12%                                    NR               Additional
                                        2000                                 Moderately diff.                36%            33%            26%                                                     information
                                        10647666                             Poorly diff./                   55%            55%            48%                                                     is
                                                                             undifferentiated                39%            38%            36%                                                     presented
                                                                             Percentage of                   (1988)         (1992)         (1995)                                                  in Figure 5
                                                                             prostate cancer                                                                                                       of the
                                                                             deaths out of                                                                                                         paper.
                                                                             all deaths
                                                                             observed
                                                                             among
                                                                             prostate cancer
                                                                             patients
























                                                                                                                        C-47
   253   254   255   256   257   258   259   260   261   262   263